Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: Association with pathological response to treatment and clinical outcome

Gynecologic Oncology

Volumn 103, Issue 2, 2006, Pages 500-505

  Ferrandina, Gabriella ^a,b   Distefano, Mariagrazia ^a   Smaniotto, Daniela ^a   Morganti, Alessio ^b   Paglia, Amelia ^a   Macchia, Gabriella ^b   Corvari, Barbara ^a   Lorusso, Domenica ^b   Scambia, Giovanni ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Anemia; Locally advanced cervical carcinoma; Preoperative radiochemotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL; HEMOGLOBIN A;

ADJUVANT THERAPY; ADULT; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE FREE SURVIVAL; DRUG INFUSION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; ITALY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PREOPERATIVE CARE; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 33750154758     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.03.039     Document Type: Article

References (40)

1. Keys H.M., Bundy B.N., Stehman F.B., Muderspach L.I., Chafe W.E., Suggs C.L., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Eng J Med 340 (1999) 1154-1161
2. Morris M., Eifel P.J., Lu J., Grigsby P.W., Levenbach L.I., Stevens R.E., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Eng J Med 340 (1999) 1137-1143
3. Whitney C.W., Sauser W., Bundy B.N., Malfetano J.H., Hannigan E.V., Fowler W.C., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17 (1999) 1339-1348
4. Rose P.G., Bundy B.N., Watkins E.B., Thigpen J.T., Deppe G., Maiman M.A., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Eng J Med 340 (1999) 1144-1153
5. Pearcy R., Brundage M., Drouin P., Jeffrey J., Johnston D., Lukka H., et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 20 (2002) 966-972
6. Green J., Kirwan J., Tierney J., Symonds P., Fresco L., Williams C., et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 3 (2005) [CD002225]
7. Resbeut M., Cowen D., Viens P., Noirclerc M., Perez T., Gouvernet J., et al. Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma. Gynecol Oncol 54 (1994) 68-75
8. Jurado M., Martinez-Monge R., Garcia-Foncillas J., Azinovic I., Aristu J., Lopez-Garcia G., et al. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radiotherapy in locally advanced cervical cancer. Gynecol Oncol 74 (1999) 30-37
9. Mancuso S., Smaniotto D., Benedetti Panici P., Favale B., Greggi S., Manfredi R., et al. Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma. Gynecol Oncol 78 (2000) 324-328
10. Distefano M., Ferrandina G., Smaniotto D., Margariti A.P., Zannoni G., Macchia G., et al. Concomitant radiochemotherapy plus surgery in locally advanced cervical cancer: update of clinical outcome and cyclooxygenase-2 as predictor of treatment susceptibility. Oncology 67 (2004) 103-111
11. Distefano M., Fagotti A., Ferrandina G., Fanfani F., Smaniotto D., D'Agostino G., et al. Preoperative chemoradiotherapy in locally advanced cervical cancer: long term outcome and complications. Gynecol Oncol 99 (2005) S166-S170
12. Houvenaegel G., Lelievre L., Gonzague-Casabianca L., Buttarelli M., Moutardier V., Goncalves A., et al. Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma. Gynecol Oncol 100 (2006) 338-343
13. Grogan M., Thomas G.M., Melamed I., Wong F.L.W., Pearcey R.G., Joseph P.K., et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 86 (1999) 1528-1536
14. Dunst J., Kuhnt T., Strauss H.G., Krause U., Pelz T., Koelbl H., et al. Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int J Radiat Oncol Biol Phys 56 3 (2003) 778-787
15. Girinski T., Pejovic-Lenfant M.H., Bourhis J., Campana F., Cosset J.M., Petit C., et al. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients. Int J Radiat Oncol Biol Phys 16 (1989) 37-42
16. Harrison L.B., Chadha M., Hill R.J., Hu K., and Shasha D. Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist 7 (2002) 492-508
17. Höckel M., Schlenger K., Höckel S., and Vaupel P. Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res 59 (1999) 4525-4528
18. Obermair A., Cheuk R., Horwoods K., Janda M., Bachtiary, Schwanzelberger B., et al. Impact of haemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma: preliminary results. Cancer 92 (2001) 903-908
19. Obermair A., Cheuk R., Horwoods K., Neudorfer M., Janda M., Giannis G., et al. Anemia before and during concurrent chemoradiotherapy in patients with cervical carcinoma: effect on progression-free survival. Int J Gynecol Cancer 13 (2003) 633-639
20. Munsted K., Johnson P., Bohlmann M.K., Zygmunt M., von Georgi R., and Vahrson H. Adjuvant radiotherapy in carcinomas of the uterine cervix: the prognostic value of haemoglobin levels. Int J Gynecol Cancer 15 (2005) 285-291
21. Piver M.S., Rutledge F., and Smith J.P. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 44 (1974) 265-272
22. Perez C.A., and Brady L.W. Overview. In: Perez C.A., and Brady L.W. (Eds). Principles and practices of radiation oncology. 5th ed. (1992), Lippincott, Philadelphia 1-63
23. World Health Organization. WHO handbook for reporting results of cancer treatment vol. 48 (1979), WHO, Geneva 16-21 Offset publication no.
24. Kaplan E.L., and Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 53 (1985) 457-481
25. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50 (1966) 163-170
26. Cox D.R. Analysis of binary data (1970), Methven, London
27. Cox D.R. Regression models and life tables. J R Stat Soc 34 (1972) 197-220
28. Glaser C.M., Millesi W., Kornek G., Lang S., Schull B., Watzinger F., et al. Impact of haemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 50 3 (2001) 705-715
29. Rofstad E.K., Sundford K., Lyng H., and Trope C.G. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis. Br J Cancer 83 (2000) 354-358
30. Palcic B., and Skarsgard L.D. Reduced oxygen enhancement ratio at low doses of ionising radiation therapy. Int J Radiat Oncol Biol Phys 12 (1986) 2047-2050
31. Teicher B.A., Holden S.A., and Rose C.M. Effect of oxygen on the cytotoxicity and tumor activity of etoposide. J Natl Cancer Inst 75 (1985) 1129-1133
32. Teicher B.A. Hypoxia and drug resistance. Cancer Metastasis Rev 13 (1994) 39-68
33. Ishikawa H., Sakurai H., Hasegawa M., Mitsuhashi N., Takahashi M., Masuda N., et al. Expression of hypoxic-inducible 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma. Int J Radiat Oncol Biol Phys 60 2 (2004) 513-521
34. Kaluz S., Kaluzova M., and Stanbridge E.J. Expression of the hypoxia marker carbonic anhydrase IX is critically dependent on SP1 activity. Identification of a novel type of hypoxia-responsive enhancer. Cancer Res 63 5 (2003) 917-922
35. Royds J.A., Dower S.K., Qwarnstrom E.E., and Lewis C.E. Response of tumour cells to hypoxia: role of p53 and NFkB. Mol Pathol 51 2 (1998) 55-61
36. Hockel M., Schlenger K., Aral B., Mitze M., Schaffer U., and Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56 (1996) 4509-4515
37. Tanaka H., Yasuda Y., Musha T., Ueda K., and Nakamura Y. Hypoxia correlates with angiogenesis in cervical cancers. Int J Clin Oncol 10 1 (2005) 35-39
38. Classe J.M., Morice P., Rodier J., Rauch P., Lasry S., and Houvenaeghel G. Pathological evaluation of pelvic radiotherapy with concurrent cisplatin-based chemotherapy followed by surgery in treatment of locally advanced cervical cancer: a retrospective multicentic experience of French Federation of Cancer Centers. Eur J Surg Oncol 28 3 (2002) 61 [Abstr]
39. Bush R. The significance of anemia in clinical radiation therapy. Int J Radiat Oncol Biol Phys 12 (1986) 2047-2050
40. Lavey R.S., Liu P.Y., Greer B.E., Robinson W.R., Chang P.C., Wynn R.B., et al. Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study. Gynecol Oncol 95 (2004) 145-151